Sunitinib in thymic carcinoma: enigmas still unresolved
- PMID: 25592633
- DOI: 10.1016/S1470-2045(15)70010-0
Sunitinib in thymic carcinoma: enigmas still unresolved
Comment on
-
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.Lancet Oncol. 2015 Feb;16(2):177-86. doi: 10.1016/S1470-2045(14)71181-7. Epub 2015 Jan 13. Lancet Oncol. 2015. PMID: 25592632 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical